Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2014
10/16/2014US20140309610 Drug Delivery Device Comprising Silicon-Based Carrier Particles
10/16/2014US20140309598 Osmotically active vaginal delivery system
10/16/2014US20140309563 Vibrating stimulus pad
10/16/2014US20140309301 Antiviral treatments
10/16/2014US20140309277 Lipids, lipid compositions, and methods of using them
10/16/2014US20140309238 Fluoralkylcarbonyl-oxadiazoles
10/16/2014US20140309236 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
10/16/2014US20140309217 Controlled-Release CNS Modulating Compositions and Methods for the Treatment of Otic Disorders
10/16/2014US20140309204 Steroid hormone products and methods for preparing them
10/16/2014US20140309201 Compositions for Providing Vitamin D Year Round and Uses Thereof
10/16/2014US20140309198 Method of treating acne
10/16/2014US20140309173 Peptides For Skin Rejuvenation And Methods Of Using The Same
10/16/2014US20140308363 Drug loaded polymeric nanoparticles and methods of making and using same
10/16/2014US20140308361 Composition for management of periodontal diseases
10/16/2014US20140308360 Nanoparticles and nanoparticle compositions
10/16/2014US20140308359 Easily dosable solid preparation
10/16/2014US20140308358 Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
10/16/2014US20140308357 Melatonin-based solutions and powders for their preparation
10/16/2014US20140308356 Granular material for dosage forms
10/16/2014US20140308354 Sustained release bimatoprost, bimatoprost analogs, prostamides and prostaglandins for fat reduction
10/16/2014US20140308353 Delivery of an active material
10/16/2014US20140308352 Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
10/16/2014US20140308351 Method of Forming Non-Immunogenic Hydrophobic Protein Nanoparticles, and Uses Therefor
10/16/2014US20140308349 Pharmaceutical compositions
10/16/2014US20140308348 Flurbiprofen and muscle relaxant combinations
10/16/2014US20140308343 Method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, and the use thereof
10/16/2014US20140308339 Lipophilic drug delivery vehicle and methods of use thereof
10/16/2014US20140308338 Dressings that contain active substance
10/16/2014US20140308336 Local drug delivery devices and methods for treating cancer
10/16/2014US20140308335 Transdermal preparation
10/16/2014US20140308331 Interpolymer network delivery system
10/16/2014US20140308304 Lipids for the delivery of active agents
10/16/2014US20140308293 Reconstitution method for high concentration dry protein formulations
10/16/2014US20140308223 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
10/16/2014US20140308212 Edible plant-derived microvesicle compositions for diagnosis and treatment of disease
10/16/2014US20140305835 Packaging and dispensing of rapid dissolve dosage form
10/14/2014USRE45196 Compositions comprising structurally stable conjugate molecules
10/14/2014USRE45195 Compositions and methods for enhancing contrast in imaging
10/14/2014US8862223 Active transdermal medicament patch and circuit board for same
10/14/2014US8859727 Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
10/14/2014US8859716 Degradable thiol-ene polymers
10/14/2014US8859624 Stable rasagiline composition
10/14/2014US8859621 Pharmaceutical formulations of modafinil
10/14/2014US8859619 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
10/14/2014US8859603 Method for solubilizing metronidazole
10/14/2014US8859593 Composition for improving cognition and memory
10/14/2014US8859589 Use of 4′-thio-2′-deoxynucleosides as anti orthopoxvirus agents
10/14/2014US8859585 Scopolamine for the treatment of depression and anxiety
10/14/2014US8859554 Packaging assembly for pharmaceutical composition including pimobendan
10/14/2014US8859550 Heterocyclic inhibitors of histamine receptors for the treatment of disease
10/14/2014US8859544 Indolizine derivatives, process for the preparation thereof and therapeutic use thereof
10/14/2014US8859528 Compositions and methods for modulation of vascular structure and/or function
10/14/2014US8859525 Pharmaceutical compositions comprising mushroom-based polysaccharides and uses thereof
10/14/2014US8859523 Crosslinked compounds and methods of making and using thereof
10/14/2014US8859506 Glycopeptide phosphonate derivatives
10/14/2014US8859499 Method of enhancing efficacy of blood transfusions
10/14/2014US8859487 Perfume testers or perfumes
10/14/2014US8859288 pH-sensitive microparticles with matrix-dispersed active agent
10/14/2014US8859274 Antibody fragment-targeted immunoliposomes for systemic gene delivery
10/14/2014US8859011 Calcium compositions
10/14/2014US8859010 Method of producing eggshell powder
10/14/2014US8859006 Semen cassiae soft capsule for reducing fat and losing weight and preparation method thereof
10/14/2014US8859005 Enteric delivery of functional ingredients suitable for hot comestible applications
10/14/2014US8859004 pH-sensitive nanoparticles for oral insulin delivery
10/14/2014US8859003 Preparation of an enteric release system
10/14/2014US8859002 Method for the dry dispersion of nanoparticles and the production of hierarchical structures and coatings
10/14/2014US8859001 Fenoldopam formulations and pro-drug derivatives
10/14/2014US8859000 Synthesis of nanoparticles by an emulsion-gas contacting process
10/14/2014US8858999 Method to produce hyaluronic acid functionalized derivatives and formation of hydrogels thereof
10/14/2014US8858998 Thermoresponsive arginine-based hydrogels as biologic carriers
10/14/2014US8858997 Formulations and methods for lyophilization and lyophilates provided thereby
10/14/2014US8858996 Pharmaceutical compositions for the coordinated delivery of NSAIDS
10/14/2014US8858995 Methods and compositions for controlled delivery of phytochemical agents
10/14/2014US8858994 Pharmaceutical formulation comprising ezetimibe
10/14/2014US8858993 Coated tablet with zero-order or near zero-order release kinetics
10/14/2014US8858992 High drug load mesalazine sachet
10/14/2014US8858991 Delayed release oral pharmaceutical dosage forms comprising MGBG
10/14/2014US8858990 Capsule of thermogenic cells for treating a metabolic disease
10/14/2014US8858989 Gel-formulations of hydrophobic photosensitizers for mucosal applications
10/14/2014US8858988 Compositions comprising extracts of Boswellia, tea tree, aloe and lavender oil and methods of treating wounds, burns and skin injuries therewith
10/14/2014US8858985 Films comprising a liquid-absorbant inner layer, an antimicrobial material and an impermeable outer layer
10/14/2014US8858984 Buccal drug delivery
10/14/2014US8858983 Antioxidants and antimicrobial accessories including antioxidants
10/14/2014US8858982 Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
10/14/2014US8858978 Heat cured gel and method of making
10/14/2014US8858977 Drug delivery system
10/14/2014US8858976 Implantable paste and its use
10/14/2014US8858974 Device and methods for treating paranasal sinus conditions
10/14/2014US8858973 Granular turf safe mesotrione compositions
10/14/2014US8858971 Epidermal cooling
10/14/2014US8858970 High load dispersions
10/14/2014US8858969 Hemostatic compositions, devices, and methods
10/14/2014US8858967 Dermatological cream-gels containing avermectin compounds
10/14/2014US8858966 Methods and compositions for the treatment of open and closed wound spinal cord injuries
10/14/2014US8858965 Micelle encapsulation of a combination of therapeutic agents
10/14/2014US8858964 Anti-bacterial applications of poly-N-acetylglucosamine nanofibers
10/14/2014US8858963 Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
10/14/2014US8858962 Adjuvant or pharmaceutical preparation for transdermal or transmucosal administration
10/14/2014US8858961 Compositions containing alpha-2-adrenergic agonist components
10/14/2014US8858960 Method of producing a pharmaceutical product
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 2991